Cancer patients given fluids live longer

January 10, 2018, University of Surrey

Dying cancer patients given fluids will generally live longer, a new study led by researchers from Royal Surrey County Hospital NHS Foundation Trust and the University of Surrey has found.

End-of-life receiving assisted hydration had a 26 per cent greater survival, which meant that they lived for on average one-and-a-half more days, compared to those who were not receiving such treatment.

Over a year more than 200 , who were in the last week of their life, took part in the study at four cancer centres and eight hospices across the country.

All of the participants, aged between 28 and 98 years, were unable to maintain sufficient intake on their own and as a result received it either intravenously, administered directly into a vein, or subcutaneously, delivered under the skin.

They were assessed every four hours, with the teams collecting data on clinical problems, interventions and overall survival.

As well as increasing life by an average of one-and-a-half days, patients' receiving fluids were also found to have good symptom control, and to suffer from minimal side effects.

A further study is now planned to continue to evaluate the role that providing fluids plays in end of life care.

Andrew Davies, a consultant in Palliative Medicine at Royal Surrey, said: "The provision of clinically assisted hydration at the end-of-life is one of the most contentious issues in medicine.

"The results of this study are certainly interesting, but a larger study is needed to confirm the role of clinically assisted hydration at the end of life".

"For some patients and their families living an extra day or so may be extremely important, as it can give them an opportunity to say their goodbyes, have family arrive from abroad, write a will or even get married.

"Nevertheless, for other patients, living an extra day or so may be the worst thing possible."

Dr. Agnieszka Michael, Medical Director of the Clinical Trials Unit at the University of Surrey, said: "Hydration of dying patients in palliative care delivers the gift of time however this is not a gift that all patients and their families desire.

"Hydration plays a key role in delaying the dying process, why this is remains unknown. We will be exploring this in further studies and the results from this will help improve quality in end of care."

Explore further: Italy OKs living wills amid long-running euthanasia debate

More information: A cluster randomised feasibility trial of clinically assisted hydration in cancer patients in the last days of life. Journal of Palliative Medicine. DOI: 10.1177/0269216317741572

Related Stories

Italy OKs living wills amid long-running euthanasia debate

December 14, 2017
Italy's Senate gave final approval Thursday to a law allowing Italians to write living wills and refuse artificial nutrition and hydration, the latest step in the Roman Catholic nation's long-running and agonizing debate ...

Dying patients who received palliative care visited the ER less

February 21, 2017
Community-based palliative care—care delivered at home, not the hospital—was associated with a 50 percent reduction in emergency department visits for patients in their last year of life. The results of an Australian ...

Parenteral hydration no benefit for cancer care in hospices

November 28, 2012
(HealthDay)—For patients with advanced cancer in hospices, providing parenteral saline (1 liter per day) does not improve symptoms associated with dehydration, quality of life, or overall survival compared with placebo, ...

Most nursing home residents eligible for palliative care but lack access

November 21, 2017
Nearly 70 percent of nursing home residents are eligible for palliative care, but do not receive any corresponding support to provide relief from their symptoms and improve their quality of life, according to a study by researchers ...

Choosing to die at home does not hasten death for patients with terminal cancer

March 28, 2016
A large study from Japan found that cancer patients who died at home tended to live longer than those who died in hospitals. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings ...

Research examines benefits of palliative care in heart failure treatment

October 18, 2017
Patients living with heart failure receive palliative care significantly less often than patients with other illnesses, including cancer, despite evidence that such care improves symptom management and quality of life.

Recommended for you

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.